Download PDF
TumorDiagnostik & Therapie 2016; 37(04): 180-183
DOI: 10.1055/s-0042-105266
Schwerpunkt: Krebsprävention und Prähabilitation
Georg Thieme Verlag KG Stuttgart · New York

Übersicht – Krebsprävention und Prähabilitation

R. Merz
Further Information

Publication History

Publication Date:
24 May 2016 (online)

Also available at
    Permissions and Reprints

Die Krebsprävention umfasst alle Maßnahmen und Aktivitäten, die das Entstehen einer Krebserkrankung verhindern, weniger wahrscheinlich machen oder verzögern. Ziele der Prävention sind die Senkung der Häufigkeit, Dauer und Schwere einer Krebserkrankung sowie die Erhöhung der krankheitsfreien Lebenserwartung.

 

  • Literatur

  • 1 Caplan G. Principles of preventive psychiatry. New York: Basic Books; 1964
    Google Scholar
  • 2 Coyle YM. Lifestyle, genes, and cancer. Methods Mol Biol 2009; 472: 25-56
    PubMedGoogle Scholar
  • 3 Sachverständigenrat für die Konzertierte Aktion im Gesundheitswesen. Gutachten 2000/2001. Bedarfsgerechtigkeit und Wirtschaftlichkeit. Band I Zielbildung, Prävention, Nutzerorientierung und Partizipation. Baden-Baden: Nomos; 2002
    Google Scholar
  • 4 European Code Against Cancer 4th edition. Cancer Epidemiol 2015; 39: s1-s10
    CrossrefPubMedGoogle Scholar
  • 5 Harvard Report on Cancer Prevention. Volume 1: Causes of human cancer. Cancer Causes Contr 1996; 7: 53-59
    PubMedGoogle Scholar
  • 6 Do not smoke; if you smoke, stop doing so. If you fail to stop, do not smoke in the presence of non-smokers. Abgerufen am 16. März 2016 http://www.cancercode.org
    PubMedGoogle Scholar
  • 7 Spitz M. Epidemiology and risk factors for head and neck cancer. Semin Oncol 1994; 21: 281-288
    PubMedGoogle Scholar
  • 8 Reynolds P, Hurley S, Goldberg DE et al. Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst 2004; 96: 29-37
    CrossrefPubMedGoogle Scholar
  • 9 Botteri E, Iodice S, Bagnardi V et al. Smoking and colorectal cancer: a meta-analysis. JAMA 2008; 300: 2765-2778
    CrossrefPubMedGoogle Scholar
  • 10 Khan N, Afaq F, Mukhtar H. Lifestyle as risk factor for cancer: Evidence from human studies. Cancer Lett 2010; 293: 133-143
    CrossrefPubMedGoogle Scholar
  • 11 Morch LS, Johansen D, Thygesen LC et al. Alcohol drinking, consumption patterns and breast cancer among Danish nurses: a cohort study. Eur J Public Health 2007; 17: 624-629
    CrossrefPubMedGoogle Scholar
  • 12 Oliveria SA, Saraiya M, Geller AC et al. Sun exposure and risk of melanoma. Arch Dis Child 2006; 91: 131-138
    PubMedGoogle Scholar
  • 13 Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001; 10: 15-32
    CrossrefPubMedGoogle Scholar
  • 14 Pischon T, Lahmann PH, Boeing H et al. Body size and risk of colon and rectal cancer in the European prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst 2006; 98: 920-931
    CrossrefPubMedGoogle Scholar
  • 15 Infektiöse Erreger. Vom 6. November 2007, abgerufen am 27. Februar 2010 http://www.krebsatlas.de
    PubMedGoogle Scholar
  • 16 Chang MH. Cancer prevention by vaccination against hepatitis B. Rec Res Cancer Res 2009; 181: 85-94
    PubMedGoogle Scholar
  • 17 Gillison ML, Chaturvedi AK, Lowy DR et al. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008; 113: 3036-3046
    CrossrefPubMedGoogle Scholar
  • 18 Lynge E, Clausen LB, Guignard R, Po II P. What happens when Organization of cervical Cancer Screening is delayed or stop-ped?. J Med Screen 2006; 13: 41-46
    CrossrefPubMedGoogle Scholar
  • 19 Schäfer C. Krebsfrüherkennungsprogramme in Deutschland – eine zwiespältige Bilanz. Tumordiagn u Ther 2011; 32: 12-15
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Brenner H, Chang-Claude J, Jansen L et al. Reduced risk of colorectal cancer up to 10 years after screening surveillance or diagnostic colonoscopy. Gastroenterology 2014; 146: 709-717
    CrossrefPubMedGoogle Scholar
  • 21 Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. Brit Med J 2014; 348: g2467
    PubMedGoogle Scholar
  • 22 Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Breast Cancer Group 2013; DOI: 10.1002/14651858.CD001877.pub5.
    PubMedGoogle Scholar
  • 23 Schröder FH, Hugosson J, Roobol MJ et al. Screening and prostate cancer mortality in a randomized european study. N Engl J Med 2009; 360: 1320-1328
    CrossrefPubMedGoogle Scholar
  • 24 Andriole GL, Crawford DE, Grubb RL et al. Mortality results from a randomized protstate cancer screening trial. N Engl J Med 2009; 360: 1310-1319
    CrossrefPubMedGoogle Scholar
  • 25 Djulbegovic M, Beyth RJ, Neuberger MM et al. Screening for prostate cancer: systematic review and metaanalysis of randomised controlled trials. BMJ 2010; 341: c4543
    CrossrefPubMedGoogle Scholar
  • 26 Walter U, Schwartz FW. Prävention. In: Schwartz FW, Badura B, Busse R, Leidl R, Raspe H, Siegrist J, Walter U, (Hrsg.) Das Public Health Buch. Gesundheit und Gesundheitswesen. München, Wien, Baltimore: Urban & Fischer; 2003: 189-214
    Google Scholar
  • 27 de Paleville DT, Topp RV, Swank AM. Effects of aerobic training prior to and during chemotherapy in a breast cancer patient: A case study. J Strength Cond Res 2007; 21: 635Y7
    PubMedGoogle Scholar